MedTrace Logo

The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study

NCT00739115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2015-08-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and utility of using heliox gas in combination with nasal CPAP in premature infants. The investigators hypothesize that using heliox gas in combination with nasal CPAP will results in decreased early nasal CPAP failure requiring intubation and mechanical ventilation.

Conditions

  • Respiratory Distress Syndrome, Newborn

Interventions

OTHER

Heliox gas

Heliox gas used in conjunction with nasal CPAP

Sponsors & Collaborators

  • Hawaii Community Foundation

    collaborator OTHER

  • Hawaii Medical Service Association

    collaborator OTHER

  • Hawaii Pacific Health

    lead OTHER

Principal Investigators

  • Taylor Sawyer, DO · Kapiolani Medical Center For Women & Children

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Minute
Max Age
12 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00739115 on ClinicalTrials.gov